|
10 Sep 2020 |
FDA Approves Trelegy Ellipta as the First Once-Daily Single Inhaler Triple Therapy for the Treatment of Both Asthma and COPD in the US
|
|
10 Sep 2020 |
Takeda Announces Results from Phase 3 Clinical Trial Evaluating NINLARO™ (ixazomib) in Newly Diagnosed Multiple Myeloma
|
|
10 Sep 2020 |
Statement on AstraZeneca Oxford SARS-CoV-2 vaccine, AZD1222, COVID-19 vaccine trials temporary pause
|
|
09 Sep 2020 |
Alligator Bioscience presents an update regarding the Phase I study with the drug candidate ATOR-1015
|
|
09 Sep 2020 |
REGENXBIO Announces Dosing of First Patient in Phase II AAVIATE™ Trial of RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery
|
|
09 Sep 2020 |
Bayer collaborates with Recursion to strengthen digital drug discovery and advance new therapies for fibrotic diseases
|
|
09 Sep 2020 |
Merck Announces Positive Topline Results from Two Phase 3 Adult Studies Evaluating V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Vaccine, Including Pivotal Trial
|
|
09 Sep 2020 |
Ascendis Pharma A/S Submits Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TransCon™ hGH for Treatment of Pediatric Growth Hormone Deficiency
|
|
09 Sep 2020 |
NKMax America Announces a Clinical Trial Collaboration and Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer
|
|
09 Sep 2020 |
Enterome - First Patient Dosed in a Phase 1/2 Trial with EO2401, an Innovative 'OncoMimic' based Immunotherapy Candidate Targeting Adrenal Tumors
|
|
09 Sep 2020 |
Eveliqure announces the award of a NIAID contract to finance Phase 2 clinical studies of its combined Shigella and ETEC vaccine candidate
|
|
09 Sep 2020 |
Biopharma Leaders Unite to Stand with Science
|
|
09 Sep 2020 |
Genentech Expands Its Multiple Sclerosis Portfolio With Investigational BTK Inhibitor Fenebrutinib and Initiates Novel Clinical Trials for Ocrevus (ocrelizumab)
|
|
09 Sep 2020 |
Amryt announces positive top line results from pivotal phase 3 “EASE” trial of Filsuvez in epidermolysis bullosa
|
|
08 Sep 2020 |
Albireo Phase 3 Trial Meets Both Primary Endpoints for Odevixibat in PFIC
|
|
08 Sep 2020 |
AnGes and Brickell Biotech Announce a Collaboration Agreement for the Development of a Novel DNA Vaccine Candidate for COVID-19 in the U.S.
|
|
08 Sep 2020 |
Allena Pharmaceuticals Doses First Subject in Phase 1 Clinical Trial of ALLN-346, in Development for the Treatment of Hyperuricemia in Patients with Gout and Advanced Chronic Kidney Disease
|
|
08 Sep 2020 |
Vaxart’s Oral COVID-19 Vaccine Candidate Induces Potent Systemic and Mucosal Immune Responses in Preclinical Studies
|
|
08 Sep 2020 |
Vaxil Announces Positive Results on CorVax™ in vivo Study
|
|
08 Sep 2020 |
Compugen Doses First Patient in Phase 1/2 Triple Combination Study of COM701 with Bristol Myers Squibb's Opdivo® and Anti-TIGIT Antibody
|
